X
26Aug

Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla

Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By: Robins Kaplan LLP
Source Url: https://www.jdsupra.com/legalnews/financial-daily-dose-8-26-2019-top-43922/

Related

Print Shoot Pay Delay

Finally, an employer-friendly law passed in California! Unfortunately, it only affects a small numbe...

Read More >

Predictive Scheduling for Chicago Too.

Last week, the Chicago City Council passed the Chicago Fair Workweek Ordinance (“the Ordinance”), ...

Read More >

Expanding the National Security review of foreign investments - Long-awaited regulations provide definitions, exceptions and some controversy

The Committee on Foreign Investment in the United States (“CFIUS”) has now released for public com...

Read More >

Not So Severable After All: Third Circuit Lets Courts Determine Arbitration Agreement Existence When Underlying Contract’s Validity Is Challenged

On September 14, the U.S. Court of Appeals for the Third Circuit addressed the perennially thorny is...

Read More >

International Employee Stock Plans: 2019 Mid-Year Developments

This White Paper highlights some recent developments in certain countries relating to employee stock...

Read More >

H-1B Lottery Registration - New Process

United States Citizenship and Immigration Service (USCIS) has implemented a new process for the annu...

Read More >